|
WO2021049980A1
|
|
Novel compositions for treatment and prophylaxis of viral diseases
|
|
MD20200004A2
|
|
L-enantiomer 2-ethyl-6-methyl-3-hydroxypyridinium L-hydroxybutandioate with cerebroprotective, hepatoprotective, lipid-regulating, anti-ischemic and neurotropic activities
|
|
CN109414418A
|
|
Combined pharmaceutical composition comprising Memantine and epiphysin
|
|
BR112018016725A2
|
|
pharmaceutical composition to prevent and treat sleep disorders
|
|
UA122914C2
|
|
Clozapine tablets with sustained release and method for manufacturing same
|
|
WO2017095266A1
|
|
Pharmaceutical composition for topical application for treating infectious inflammatory diseases, and method for producing and using same (variants)
|
|
CN107205944A
|
|
For correcting weak and/or chronic fatigue syndrome symptom or treating weak and/or chronic fatigue syndrome pharmaceutical composition
|
|
SG11201505385VA
|
|
Pharmaceutical composition in the form of a tabletand a method for producing same
|
|
WO2014054965A1
|
|
Combination for the prophylaxis and treatment of behavioural, mental and cognitive disorders
|
|
CN104023719A
|
|
Use of glutaryl histamine to treat respiratory tract infections
|
